Milestone Pharmaceuticals Inc

자세한 내용은 Milestone Pharmaceuticals Inc 회사

Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.

회사 정보

종목 코드 MIST

회사 이름Milestone Pharmaceuticals Inc

상장일May 09, 2019

CEOMr. Joseph Oliveto

직원 수33

유형Ordinary Share

회계 연도 종료May 09

주소420-1111 boul. Dr.-Frederik-Philips

도시MONTREAL

증권 거래소NASDAQ Global Select Consolidated

국가Canada

우편 번호H4M 2X6

전화15143360444

웹사이트https://www.milestonepharma.com

종목 코드 MIST

상장일May 09, 2019

CEOMr. Joseph Oliveto

회사 임원

이름

이름/직위

직위

주식 보유

변동

Dr. David Bharucha

Chief Medical Officer

78.45K

+212.30%

Mr. Amit Hasija

Chief Financial Officer, Executive Vice President - Corporate Development

69.20K

+260.35%

Dr. Robert James Wills, Ph.D.

Non-Executive Independent Chairman of the Board

65.00K

+333.33%

Mr. Michael John Tomsicek

Independent Director

15.00K

--

Mr. Stuart Duty

Independent Director

--

Mr. Joeseph C. Papa

Independent Director

--

Mr. Andrew Saik

Independent Director

--

Ms. Lisa M. Giles

Independent Director

--

Mr. Joseph Oliveto

President, Chief Executive Officer, Director

--

Mr. Lorenz Muller

Chief Commercial Officer

--

이름

이름/직위

직위

주식 보유

변동

Dr. David Bharucha

Chief Medical Officer

78.45K

+212.30%

Mr. Amit Hasija

Chief Financial Officer, Executive Vice President - Corporate Development

69.20K

+260.35%

Dr. Robert James Wills, Ph.D.

Non-Executive Independent Chairman of the Board

65.00K

+333.33%

Mr. Michael John Tomsicek

Independent Director

15.00K

--

Mr. Stuart Duty

Independent Director

--

Mr. Joeseph C. Papa

Independent Director

--

수익 분석

데이터 없음

데이터 없음

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Sat, Jul 26

주주

주주 유형

주주

비율

Trails Edge Capital Partners LP

6.28%

Oliveto (Joseph Gerard)

2.95%

RTW Investments L.P.

2.95%

Propel Bio Management, LLC

1.71%

Alta Fundamental Advisers LLC

1.68%

Other

84.43%

주주

비율

Trails Edge Capital Partners LP

6.28%

Oliveto (Joseph Gerard)

2.95%

RTW Investments L.P.

2.95%

Propel Bio Management, LLC

1.71%

Alta Fundamental Advisers LLC

1.68%

Other

84.43%

주주 유형

주주

비율

Investment Advisor

9.84%

Individual Investor

3.61%

Investment Advisor/Hedge Fund

3.37%

Hedge Fund

2.90%

Research Firm

2.38%

Venture Capital

1.77%

Bank and Trust

0.03%

Other

76.11%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

98

14.43M

18.73%

-14.88M

2025Q1

102

12.26M

22.94%

-17.24M

2024Q4

99

25.17M

47.19%

-9.38M

2024Q3

113

29.31M

55.02%

-13.44M

2024Q2

115

30.81M

57.87%

-11.80M

2024Q1

116

31.96M

60.43%

+3.19M

2023Q4

112

18.49M

55.02%

-13.59M

2023Q3

109

20.24M

60.32%

-12.06M

2023Q2

108

21.35M

63.87%

-11.78M

2023Q1

110

22.19M

66.58%

-11.98M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Oliveto (Joseph Gerard)

2.44M

4.57%

+2.16M

+756.94%

Apr 15, 2025

RTW Investments L.P.

2.51M

4.69%

--

Mar 31, 2025

Propel Bio Management, LLC

1.45M

2.71%

+1.25M

+625.78%

Mar 31, 2025

Alta Fundamental Advisers LLC

1.43M

2.67%

-1.23M

-46.31%

Mar 31, 2025

BML Capital Management LLC

1.14M

2.13%

--

Mar 31, 2025

Morgan Stanley & Co. LLC

965.92K

1.81%

-320.62K

-24.92%

Mar 31, 2025

Simplify Asset Management Inc

850.00K

1.59%

+850.00K

--

Mar 31, 2025

TD Securities, Inc.

750.00K

1.4%

--

Mar 31, 2025

Lion Point Capital, L.P.

548.81K

1.03%

-477.00K

-46.50%

Mar 31, 2025

1.495USD

Milestone Pharmaceuticals Inc

1.495

개요

회사

금융